Garde Capital, Inc. Amgen Inc Transaction History

Garde Capital, Inc.

$1.44 Billion
Q2 2024

A detailed history of Garde Capital, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Garde Capital, Inc. holds 2,237 shares of AMGN stock, worth $658,863. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,237

Previous 2,915 23.26%

Holding current value

$658,863

Previous $829,000 15.68%

% of portfolio

0.05%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	SELL	$262.75 - $319.31 $178,144 - $216,492	-678 Reduced 23.26%	2,237 $699,000
Q1 2024 May 29, 2024	BUY	$268.87 - $324.56 $1,882 - $2,271	7 Added 0.24%	2,915 $829,000
Q4 2023 Feb 21, 2024	SELL	$255.7 - $288.46 $527,509 - $595,092	-2,063 Reduced 41.5%	2,908 $838,000
Q3 2023 Nov 17, 2023	SELL	$218.65 - $271.46 $74,778 - $92,839	-342 Reduced 6.44%	4,971 $1.34 Million
Q2 2023 Aug 28, 2023	BUY	$214.27 - $253.37 $493,035 - $583,004	2,301 Added 76.39%	5,313 $1.18 Million
Q2 2022 Aug 23, 2022	BUY	$230.71 - $256.74 $17,764 - $19,768	77 Added 2.62%	3,012 $733,000
Q1 2022 May 27, 2022	BUY	$219.27 - $242.57 $42,538 - $47,058	194 Added 7.08%	2,935 $710,000
Q2 2021 Aug 19, 2021	SELL	$233.58 - $259.14 $48,117 - $53,382	-206 Reduced 6.99%	2,741 $668,000
Q1 2021 May 24, 2021	BUY	$221.91 - $258.6 $221 - $258	1 Added 0.03%	2,947 $733,000
Q4 2020 Feb 26, 2021	BUY	$216.38 - $257.67 $107,973 - $128,577	499 Added 20.39%	2,946 $677,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $41,626 - $53,504	-220 Reduced 8.25%	2,447 $590,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $16,366 - $19,610	-94 Reduced 3.4%	2,667 $516,000
Q3 2018 Nov 19, 2018	BUY	$185.29 - $208.89 $9,264 - $10,444	50 Added 1.84%	2,761 $531,000
Q2 2018 Aug 20, 2018	BUY	$166.05 - $186.51 $33,210 - $37,302	200 Added 7.96%	2,711 $500,000
Q1 2018 May 16, 2018	SELL	$169.43 - $198.0 $4,235 - $4,950	-25 Reduced 0.99%	2,511 $428,000
Q4 2017 Feb 23, 2018	BUY	$168.79 - $188.59 $21,098 - $23,573	125 Added 5.18%	2,536 $441,000
Q3 2017 Nov 17, 2017	BUY	$167.29 - $191.0 $403,336 - $460,501	2,411	2,411 $449,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Garde Capital, Inc. with notifications on news.

Account

Garde Capital, Inc. Amgen Inc Transaction History